Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies.

Kulandaisamy R, Kushwaha T, Dalal A, Kumar V, Singh D, Baswal K, Sharma P, Praneeth K, Jorwal P, Kayampeta SR, Sharma T, Maddur S, Kumar M, Kumar S, Polamarasetty A, Singh A, Sehgal D, Gholap SL, Appaiahgari MB, Katika MR, Inampudi KK

Open source

DOI: 10.3389/fmicb.2022.877813
Published: 2022
Container: Frontiers in microbiology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmicb.2022.877813,
  title = {Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies.},
  author = {Kulandaisamy R and Kushwaha T and Dalal A and Kumar V and Singh D and Baswal K and Sharma P and Praneeth K and Jorwal P and Kayampeta SR and Sharma T and Maddur S and Kumar M and Kumar S and Polamarasetty A and Singh A and Sehgal D and Gholap SL and Appaiahgari MB and Katika MR and Inampudi KK},
  year = {2022},
  journal = {Frontiers in microbiology},
  doi = {10.3389/fmicb.2022.877813},
  url = {https://doi.org/10.3389/fmicb.2022.877813}
}

RIS

TY  - JOUR
TI  - Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies.
AU  - Kulandaisamy R
AU  - Kushwaha T
AU  - Dalal A
AU  - Kumar V
AU  - Singh D
AU  - Baswal K
AU  - Sharma P
AU  - Praneeth K
AU  - Jorwal P
AU  - Kayampeta SR
AU  - Sharma T
AU  - Maddur S
AU  - Kumar M
AU  - Kumar S
AU  - Polamarasetty A
AU  - Singh A
AU  - Sehgal D
AU  - Gholap SL
AU  - Appaiahgari MB
AU  - Katika MR
AU  - Inampudi KK
PY  - 2022
JO  - Frontiers in microbiology
DO  - 10.3389/fmicb.2022.877813
UR  - https://doi.org/10.3389/fmicb.2022.877813
ER  -

APA

R, K., T, K., A, D., V, K., D, S., K, B., P, S., K, P., P, J., SR, K., T, S., S, M., M, K., S, K., A, P., A, S., D, S., SL, G., MB, A., MR, K., & KK, I. (2022). Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies.. Frontiers in microbiology. https://doi.org/10.3389/fmicb.2022.877813

Source records

pubmed · retrieved 2026-09-25T13:44:31.968Z